| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $69.6M | +3.0% |
| Cost of Revenue | $61.1M | +0.5% |
| Gross Profit | $8.5M | +24.6% |
| R&D Expense | $3.4M | +39.0% |
| SG&A Expense | $23.0M | +25.0% |
| Operating Income | -$17.8M | -27.6% |
| Interest Expense | $5.0M | -2.9% |
| Pre-tax Income | -$20.2M | -9.9% |
| Income Tax | $19K |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.6M | -54.5% |
| Accounts Receivable | $24.7M | +19.8% |
| Inventory | $18.5M | +56.1% |
| Current Assets | $71.2M | -18.1% |
| Total Assets | $100.8M | -5.0% |
| Current Liabilities | $37.6M | +9.2% |
| Long-term Debt | $51.0M | +0.0% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.5M | -1716.6% |
| Capital Expenditures | $9.9M | +209.3% |
| Investing Cash Flow | -$9.9M | -209.3% |
| Financing Cash Flow | $10.4M | -71.0% |
| Free Cash Flow | -$37.4M | -2381.6% |
| +0.0% |
| Net Income | -$20.2M | -9.9% |
| EPS (Basic) | -$1.37 | +16.0% |
| EPS (Diluted) | -$1.37 | +16.0% |
| Total Liabilities |
| $95.4M |
| +2.7% |
| Stockholders' Equity | $5.4M | -58.9% |